Report Detail
Global Diagnostic Nuclear Medicines Market Growth 2019-2024
- RnM3313422 |
- 12 April, 2019 |
- Global |
- 164 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
According to this study, over the next five years the Diagnostic Nuclear Medicines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diagnostic Nuclear Medicines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.
This study considers the Diagnostic Nuclear Medicines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tc-99m
F-18
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diagnostic Nuclear Medicines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Diagnostic Nuclear Medicines market by identifying its various subsegments.
Focuses on the key global Diagnostic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diagnostic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diagnostic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Diagnostic Nuclear Medicines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Diagnostic Nuclear Medicines Consumption 2014-2024
- 2.1.2 Diagnostic Nuclear Medicines Consumption CAGR by Region
- 2.2 Diagnostic Nuclear Medicines Segment by Type
- 2.2.1 Tc-99m
- 2.2.2 F-18
- 2.2.3 Other
- 2.3 Diagnostic Nuclear Medicines Consumption by Type
- 2.3.1 Global Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Diagnostic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Diagnostic Nuclear Medicines Sale Price by Type (2014-2019)
- 2.4 Diagnostic Nuclear Medicines Segment by Application
- 2.4.1 Oncology
- 2.4.2 Cardiology
- 2.4.3 Other
- 2.5 Diagnostic Nuclear Medicines Consumption by Application
- 2.5.1 Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Diagnostic Nuclear Medicines Value and Market Share by Application (2014-2019)
- 2.5.3 Global Diagnostic Nuclear Medicines Sale Price by Application (2014-2019)
3 Global Diagnostic Nuclear Medicines by Players
- 3.1 Global Diagnostic Nuclear Medicines Sales Market Share by Players
- 3.1.1 Global Diagnostic Nuclear Medicines Sales by Players (2017-2019)
- 3.1.2 Global Diagnostic Nuclear Medicines Sales Market Share by Players (2017-2019)
- 3.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Players
- 3.2.1 Global Diagnostic Nuclear Medicines Revenue by Players (2017-2019)
- 3.2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Players (2017-2019)
- 3.3 Global Diagnostic Nuclear Medicines Sale Price by Players
- 3.4 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Diagnostic Nuclear Medicines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Diagnostic Nuclear Medicines by Regions
- 4.1 Diagnostic Nuclear Medicines by Regions
- 4.1.1 Global Diagnostic Nuclear Medicines Consumption by Regions
- 4.1.2 Global Diagnostic Nuclear Medicines Value by Regions
- 4.2 Americas Diagnostic Nuclear Medicines Consumption Growth
- 4.3 APAC Diagnostic Nuclear Medicines Consumption Growth
- 4.4 Europe Diagnostic Nuclear Medicines Consumption Growth
- 4.5 Middle East & Africa Diagnostic Nuclear Medicines Consumption Growth
5 Americas
- 5.1 Americas Diagnostic Nuclear Medicines Consumption by Countries
- 5.1.1 Americas Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
- 5.1.2 Americas Diagnostic Nuclear Medicines Value by Countries (2014-2019)
- 5.2 Americas Diagnostic Nuclear Medicines Consumption by Type
- 5.3 Americas Diagnostic Nuclear Medicines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Diagnostic Nuclear Medicines Consumption by Countries
- 6.1.1 APAC Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
- 6.1.2 APAC Diagnostic Nuclear Medicines Value by Countries (2014-2019)
- 6.2 APAC Diagnostic Nuclear Medicines Consumption by Type
- 6.3 APAC Diagnostic Nuclear Medicines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Diagnostic Nuclear Medicines by Countries
- 7.1.1 Europe Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
- 7.1.2 Europe Diagnostic Nuclear Medicines Value by Countries (2014-2019)
- 7.2 Europe Diagnostic Nuclear Medicines Consumption by Type
- 7.3 Europe Diagnostic Nuclear Medicines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Diagnostic Nuclear Medicines by Countries
- 8.1.1 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Diagnostic Nuclear Medicines Value by Countries (2014-2019)
- 8.2 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Type
- 8.3 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Diagnostic Nuclear Medicines Distributors
- 10.3 Diagnostic Nuclear Medicines Customer
11 Global Diagnostic Nuclear Medicines Market Forecast
- 11.1 Global Diagnostic Nuclear Medicines Consumption Forecast (2019-2024)
- 11.2 Global Diagnostic Nuclear Medicines Forecast by Regions
- 11.2.1 Global Diagnostic Nuclear Medicines Forecast by Regions (2019-2024)
- 11.2.2 Global Diagnostic Nuclear Medicines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Diagnostic Nuclear Medicines Forecast by Type
- 11.8 Global Diagnostic Nuclear Medicines Forecast by Application
12 Key Players Analysis
- 12.1 Bracco Imaging
- 12.1.1 Company Details
- 12.1.2 Diagnostic Nuclear Medicines Product Offered
- 12.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Bracco Imaging News
- 12.2 Bayer
- 12.2.1 Company Details
- 12.2.2 Diagnostic Nuclear Medicines Product Offered
- 12.2.3 Bayer Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Bayer News
- 12.3 Curium Pharmaceuticals
- 12.3.1 Company Details
- 12.3.2 Diagnostic Nuclear Medicines Product Offered
- 12.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Curium Pharmaceuticals News
- 12.4 Nordion
- 12.4.1 Company Details
- 12.4.2 Diagnostic Nuclear Medicines Product Offered
- 12.4.3 Nordion Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Nordion News
- 12.5 Triad Isotopes
- 12.5.1 Company Details
- 12.5.2 Diagnostic Nuclear Medicines Product Offered
- 12.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Triad Isotopes News
- 12.6 Lantheus
- 12.6.1 Company Details
- 12.6.2 Diagnostic Nuclear Medicines Product Offered
- 12.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Lantheus News
- 12.7 GE Healthcare
- 12.7.1 Company Details
- 12.7.2 Diagnostic Nuclear Medicines Product Offered
- 12.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 GE Healthcare News
- 12.8 China Isotope & Radiation
- 12.8.1 Company Details
- 12.8.2 Diagnostic Nuclear Medicines Product Offered
- 12.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 China Isotope & Radiation News
- 12.9 Jubilant Pharma
- 12.9.1 Company Details
- 12.9.2 Diagnostic Nuclear Medicines Product Offered
- 12.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Jubilant Pharma News
- 12.10 Eli Lilly
- 12.10.1 Company Details
- 12.10.2 Diagnostic Nuclear Medicines Product Offered
- 12.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Eli Lilly News
- 12.11 Novartis
- 12.12 SIEMENS
- 12.13 Dongcheng
- 12.14 Navidea
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Diagnostic Nuclear Medicines . Industry analysis & Market Report on Diagnostic Nuclear Medicines is a syndicated market report, published as Global Diagnostic Nuclear Medicines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Diagnostic Nuclear Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
